Fine Structure Ventures

Fine Structure Ventures is a venture capital firm dedicated to early-stage investments in disruptive scientific and technological innovation. The firm employs a "first principles approach" to identify technologies that, if scaled, could achieve significant global impact. Their investment strategy spans the entire company lifecycle, from pre-seed to pre-IPO stages, backing visionary entrepreneurs who are inventing, disrupting, and building.

The firm's name, Fine Structure Ventures, is inspired by the fine-structure constant in physics, symbolizing their pursuit of unprecedented accuracy in evaluating investment opportunities and aiming for "alpha" or excess return on investment. With a legacy rooted in over 50 years of investing, Fine Structure Ventures operates as a specialized team, passionate about the transformative potential of science. As of July 1, 2024, F-Prime advises Fine Structure Ventures, which is also affiliated with FMR LLC, the parent company of Fidelity Investments.

Fine Structure Ventures focuses on a diverse range of deep tech sectors, including aerospace, biology, computing, energy, and materials. Their portfolio companies collectively boast over 300 active patents covering world-changing innovations and have raised over two billion dollars. Notable investments include companies like Commonwealth Fusion Systems, which is developing fusion energy, Mainspring Energy, focused on linear generators, Debut Biotech, utilizing cell-free biomanufacturing, Finwave Semiconductor, advancing GaN-on-Si technology, Constructive Bio, rewriting genomes for biomolecules, and iPRONICS, pioneering optical networking for AI data centers.

The team at Fine Structure Ventures comprises scientists and investors with decades of experience in investments, operations, entrepreneurship, and scientific research. Key team members include Amrit Jalan, Crissy Derome, David Needell, Dionis Minev, Jennifer Uhrig, Shyam Kamadolli, and Tobias Egle. The firm maintains an active partnership approach, holding board representation at over 80% of its portfolio companies to work closely with founders from lab-to-global scale.